| Barton, Jennifer Kehlet |
University Of Arizona
United States |
Ovarian Cancer Detection with Blood- and Imaging-Based Biomarkers |
3R01CA260399-02S1 |
PAR-19-264 (R01 Clinical Trial Optional) |
Guillermo Marquez, Ph.D. |
| Barton, Jennifer Kehlet |
University Of Arizona
United States |
Ovarian Cancer Detection with Blood- and Imaging-Based Biomarkers |
3R01CA260399-02S1 |
PAR-19-264 (R01 Clinical Trial Optional) |
Guillermo Marquez, Ph.D. |
| Bast, Robert C |
University Of Tx Md Anderson Can Ctr
United States |
MD Anderson Cancer Center EDRN- CVC for Early Detection of Ovarian Cancer |
3U01CA200462-05S1 |
|
Christos Patriotis, Ph.D., M.Sc. |
| Beretta, Laura |
University Of Tx Md Anderson Can Ctr
United States |
Early Detection of Hepatocellular Carcinoma |
5R01CA195524-07 |
PAR-19-264 (R01 Clinical Trial Optional) |
|
| Beretta, Laura |
University Of Tx Md Anderson Can Ctr
United States |
Early Detection of Hepatocellular Carcinoma |
5R01CA195524-07 |
PAR-19-264 (R01 Clinical Trial Optional) |
|
| Bertozzi, Carolyn |
Stanford University
United States |
Chemical Glycoproteomics |
5R01CA200423-19 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
Richard Mazurchuk, Ph.D. |
| Bettegowda, Chetan |
Johns Hopkins University
United States |
Interrogating malignant gliomas using released tumor DNA in cerebrospinal fluid |
5R37CA230400-05 |
|
Lynn Sorbara, Ph.D. |
| Borges, Chad R |
Arizona State University-Tempe Campus
United States |
Plate reader assays to forensically assess exposure of plasma and serum to thawed conditions |
1R21CA269091-01 |
RFA-CA-21-005 (R21 Clinical Trial Not Allowed) |
Lynn Sorbara, Ph.D. |
| Brennan, Paul Joseph |
International Agency For Res On Cancer
United States |
PROMINENT - IARC |
1OT2CA278681-01 |
|
Sharmistha Ghosh-Janjigian, Ph.D. |
| Bresalier, Robert S |
University Of Tx Md Anderson Can Ctr
United States |
Great Lakes New England Clinical Validation Center |
2U01CA086400-21 |
RFA-CA-21-033 (U01 Clinical Trial Optional) |
Jo Ann Rinaudo, Ph.D. |